Rosen E M, Laterra J, Joseph A, Jin L, Fuchs A, Way D, Witte M, Weinand M, Goldberg I D
Department of Radiation Oncology, Long Island Jewish Medical Center, Albert Einstein College of Medicine, New Hyde Park, NY, USA.
Int J Cancer. 1996 Jul 17;67(2):248-55. doi: 10.1002/(SICI)1097-0215(19960717)67:2<248::AID-IJC16>3.0.CO;2-7.
Scatter factor (SF) (also known as hepatocyte growth factor [HGF]) is a cytokine that induces cell motility in vitro and angiogenesis in vivo. SF appears to be a determinant of the malignant phenotype in certain systemic cancers. We detected SF in extracts prepared from human gliomas, with the highest levels found in malignant tumors. Human glioblastoma cells expressed both SF and its receptor (c-met protein) in vivo, as demonstrated by immunohistochemistry. Consistent with these observations, we found moderate to high levels of production of immunoreactive and biologically active SF by cultured human glioblastoma cells (3 of 8 lines) and by neural microvascular endothelial cells (NMVEC) (3 of 3 lines). SF stimulated the proliferation of glioblastoma and NMVEC cell lines by paracrine or autocrine mechanisms. Conditioned medium (CM) from both glioblastoma and NMVEC cells contained SF-inducing factor (SF-IF) activity, defined by its ability to stimulate SF production in an indicator cell line (MRC5 human fibroblasts). This activity consisted of a high-molecular-weight (> 30 kDa), heat-sensitive component and a low-molecular weight (< 30 kDa), heat-stable component. Furthermore, glioblastoma CM stimulated NMVEC SF production, and NMVEC CM stimulated glioblastoma cell SF production, by 3- to 6-fold in each case. Our findings demonstrate that SF-dependent interactions between glioma cells, and between glioma cells and endothelium, can contribute to the heterogeneous proliferative and angiogenic phenotypes of malignant gliomas in vivo.
散射因子(SF)(也称为肝细胞生长因子[HGF])是一种细胞因子,在体外可诱导细胞运动,在体内可诱导血管生成。SF似乎是某些全身性癌症恶性表型的一个决定因素。我们在人胶质瘤提取物中检测到了SF,在恶性肿瘤中含量最高。免疫组织化学显示,人胶质母细胞瘤细胞在体内同时表达SF及其受体(c-met蛋白)。与这些观察结果一致,我们发现培养的人胶质母细胞瘤细胞(8个细胞系中的3个)和神经微血管内皮细胞(NMVEC)(3个细胞系中的3个)可产生中度至高水平的免疫反应性和生物活性SF。SF通过旁分泌或自分泌机制刺激胶质母细胞瘤和NMVEC细胞系的增殖。来自胶质母细胞瘤和NMVEC细胞的条件培养基(CM)均含有SF诱导因子(SF-IF)活性,其定义为刺激指示细胞系(MRC5人成纤维细胞)中SF产生的能力。该活性由高分子量(>30 kDa)、热敏感成分和低分子量(<30 kDa)、热稳定成分组成。此外,胶质母细胞瘤CM刺激NMVEC产生SF,NMVEC CM刺激胶质母细胞瘤细胞产生SF,在每种情况下均刺激3至6倍。我们的研究结果表明,胶质瘤细胞之间以及胶质瘤细胞与内皮细胞之间的SF依赖性相互作用可导致体内恶性胶质瘤的异质性增殖和血管生成表型。